Paclitaxel (Compound)

Synonyms:33069-62-4, P88XT4IS4D, Paclitaxel, Taxol, Taxol A, Yewtaxan, Genaxol, Plaxicel, Abraxane, Ebetaxel

Pubchem:PUBCHEM:36314

Id:7d9ee30a-19a4-5123-9d9c-9aa6fcba715e

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Paclitaxel's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Paclitaxel.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Paclitaxel.

Results found

Linked to

	Label	Description
	paclitaxel negatively regulates ATP1B1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Paclitaxel indication AIDS with Kaposi's sarcoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	paclitaxel positively regulates KIF20A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	paclitaxel negatively regulates TOPBP1 Gene Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	paclitaxel negatively regulates UCP2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	paclitaxel negatively regulates IFI6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	DCSTRUCT ID 02044 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02044; PubChem_CID:36314, FILE=drugcentral_drug_02044.json)
	Paclitaxel bioactivity Tubulin beta-3 chain Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	4-(9-chloro-7-(2,6-difluorophenyl)-5H-benzo[e]pyrimido[5,4-c]azepin-2-ylamino)benzoic acid in similarity relationship with paclitaxel Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	paclitaxel positively regulates MT1G Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

paclitaxel negatively regulates ATP1B1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Paclitaxel indication AIDS with Kaposi's sarcoma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

paclitaxel positively regulates KIF20A

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

paclitaxel negatively regulates TOPBP1 Gene

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

paclitaxel negatively regulates UCP2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

paclitaxel negatively regulates IFI6

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

DCSTRUCT ID 02044

Collection (Entity type)

DrugPage Collection: (DrugCentralID:02044; PubChem_CID:36314, FILE=drugcentral_drug_02044.json)

Paclitaxel bioactivity Tubulin beta-3 chain

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

4-(9-chloro-7-(2,6-difluorophenyl)-5H-benzo[e]pyrimido[5,4-c]azepin-2-ylamino)benzoic acid in similarity relationship with paclitaxel

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

paclitaxel positively regulates MT1G

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.